RT Journal Article
SR Electronic
T1 782-E Preliminary results of an in progress, first-in-human phase 1 study of Decoy20, an intravenous, killed, multiple immune receptor agonist bacterial product in patients with advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1815
OP A1815
DO 10.1136/jitc-2023-SITC2023.0782-E
VO 11
IS Suppl 2
A1 Newman, Michael J
A1 Nieves, Jeffery A
A1 Gordon, Gary B
A1 Hanna, Diana L
A1 Alistar, Angela T
A1 Hallak, Mohammed NAl
A1 Waltzman, Roger J
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_2/A1815.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.